Deerfield Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-300,000
| Closed | -$42.5M | – | 159 |
|
|
2021
Q2 | $42.5M | Sell |
300,000
-120,000
| -29% | -$17M | 0.75% | 46 |
|
|
2021
Q1 | $41.9M | Buy |
420,000
+100,000
| +31% | +$9.97M | 0.88% | 38 |
|
|
2020
Q4 | $39.6M | Sell |
320,000
-128,000
| -29% | -$15.8M | 0.78% | 42 |
|
|
2020
Q3 | $43.6M | Buy |
448,000
+186,235
| +71% | +$18.1M | 1.06% | 29 |
|
|
2020
Q2 | $40.8M | Buy |
261,765
+77,900
| +42% | +$12.2M | 1.19% | 28 |
|
|
2020
Q1 | $26.5M | Buy |
183,865
+83,865
| +84% | +$12.1M | 0.84% | 38 |
|
|
2019
Q4 | $20.4M | Sell |
100,000
-97,000
| -49% | -$19.8M | 0.65% | 47 |
|
|
2019
Q3 | $15.8M | Hold |
197,000
| – | – | 0.64% | 49 |
|
|
2019
Q2 | $18.6M | Sell |
197,000
-167,000
| -46% | -$15.8M | 0.67% | 51 |
|
|
2019
Q1 | $31.1M | Hold |
364,000
| – | – | 1.19% | 27 |
|
|
2018
Q4 | $20.4M | Buy |
364,000
+70,000
| +24% | +$3.93M | 0.82% | 44 |
|
|
2018
Q3 | $24M | Sell |
294,000
-315,554
| -52% | -$25.8M | 0.86% | 41 |
|
|
2018
Q2 | $21.3M | Buy |
609,554
+219,554
| +56% | +$7.68M | 0.75% | 51 |
|
|
2018
Q1 | $8M | Hold |
390,000
| – | – | 0.28% | 85 |
|
|
2017
Q4 | $11M | Buy |
390,000
+200,000
| +105% | +$5.66M | 0.43% | 65 |
|
|
2017
Q3 | $5.91M | Buy |
+190,000
| New | +$5.91M | 0.27% | 76 |
|